Evoltra and acute myeloid leukaemia Patient Reports February 10, 2010

Evoltra Side Effects Report #6139727-2
Evoltra side effect was reported by a Health Professional from UNITED KINGDOM on Mar 16, 2009. Female patient, 77 years of age, was diagnosed with myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest , clostridium difficile toxin test positive, left ventricular failure, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: 42 MG, QDX5, INTRAVENOUS. During the same period patient was treated with DAUNORUBICIN, LEVOTHYROXINE, ALLOPURINOL, ACETAMINOPHEN, ONDANSETRON. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #6074383-3
Evoltra side effect was reported by a Physician from UNITED STATES on Jan 29, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, cardiac arrest , neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #6106875-2
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Feb 20, 2009. Female patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, myocardial ischaemia, neutropenic sepsis, renal failure acute. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient died on 01/25/2009.

Evoltra Side Effects Report #6020634-0
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Dec 17, 2008. Female patient, 68 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, diabetes insipidus , disease progression, hypernatraemia. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient died on 10/12/2008.


Evoltra Side Effects Report #6084210-6
Evoltra side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 03, 2009. Female patient, 68 years of age, was diagnosed with acute leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, dehydration, hypernatraemia, hypokalaemia, malignant neoplasm progression. Evoltra dosage: unknown. During the same period patient was treated with DAUNORUBICIN. Patient died on 10/12/2008.

Evoltra Side Effects Report #5960995-1
Evoltra side effect was reported by a Physician from UNITED KINGDOM on Nov 07, 2008. Female patient, 65 years of age, was diagnosed with acute leukaemia, acute myeloid leukaemia and was treated with Evoltra. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia. Evoltra dosage: 36 MG, QDX5; INTRAVENOUS. During the same period patient was treated with DAUNORUBICIN, ALLOPURINOL, ACYCLOVIR, LANSOPRAZOLE, AMIKACIN. Patient died on 10/22/2008.